|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/22/22 Biolase, Inc. S-1 3:655K Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: S-1 Registration Statement (General Form) HTML 540K 2: EX-23.1 Consent of Expert or Counsel HTML 4K 3: EX-FILING FEES Filing Fees HTML 27K
| EX-FILING FEES |
Exhibit 107.1
Calculation of Filing Fee Tables
Form S-1
(Form Type)
BIOLASE, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type |
Security Class Title | Fee Calculation Rule |
Maximum Aggregate Offering Price(1)(2) |
Fee Rate | Amount of Registration Fee | |||||
|
Equity |
Units consisting of: | 457(o) | $17,250,000 | 0.00011020 | 1,900.95 | |||||
|
Equity |
(i) Common Stock, par value $0.001 per share | 457(i) | — | — | — | |||||
|
Equity |
(ii) Warrants to purchase Common Stock | 457(i) | — | — | — | |||||
|
Equity |
Pre-Funded Units consisting of:(3) | — | — | — | — | |||||
|
Equity |
(i) Pre-Funded Warrants to purchase Common Stock | 457(i) | — | — | — | |||||
|
Equity |
(ii) Warrants to purchase Common Stock | 457(i) | — | — | — | |||||
|
Equity |
Common Stock issuable upon exercise of the Warrants | 457(o) | $17,250,000 | 0.00011020 | 1,900.95 | |||||
|
Equity |
Common Stock issuable upon exercise of the Pre-Funded Warrants(3) | — | — | — | — | |||||
|
Total Offering Amounts |
$34,500,000 | 3,801.90 | ||||||||
|
Total Fee Offsets |
— | |||||||||
|
Net Fee Due |
3,801.90 | |||||||||
| (1) | Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended. |
| (2) | Includes the aggregate offering price of any additional common stock that the underwriters have the option to purchase, if any. |
| (3) | The proposed maximum aggregate offering price of the Units proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based on the aggregate offering price of the Pre-Funded Units offered and sold in the offering (plus the aggregate exercise price of the common stock issuable upon exercise of the Pre-Funded Warrants) |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/03/23 Biolase, Inc. S-1/A 6:1M Donnelley … Solutions/FA 12/12/22 Biolase, Inc. S-1/A 7:1.1M Donnelley … Solutions/FA |